Results

Total Results: 3,041 records

Showing results for "drug".

2661. Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/studies/index.html?page=76
      January 01, 2024 - guidance was based on Clinical Pharmacogenetics Implementation Consortium guidelines (94%) and US Food and Drug

2662. Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/studies/index.html?page=115
      January 01, 2024 - clinical domains (general, hospital-acquired infections, post-procedure adverse events, and adverse drug

2663. Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/studies/index.html?page=131
      January 01, 2024 - Keywords: Blood Thinners, Medication, Medication: Safety, Adverse Drug Events (ADE), Adverse Events,

2664. Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/studies/index.html?page=95
      January 01, 2024 - The models were validated using data from the World Health Organization (WHO) HIV drug resistance report

2665. Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/studies/index.html?page=145
      January 01, 2024 - disease prevention was the largest positive contributor to life expectancy, with accidental poisoning or drug

2666. Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/studies/index.html?page=144
      January 01, 2024 - Keywords: Blood Thinners, Medication, Patient Safety, Implementation, Adverse Drug Events (ADE), Adverse

2667. Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/studies/index.html?page=107
      January 01, 2024 - Keywords: Medication: Safety, Medication, Adverse Drug Events (ADE), Medical Errors, Adverse Events,

2668. Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/studies/index.html?page=123
      January 01, 2024 - more important than other acute care settings for controlling CRE, and regional efforts to control drug-resistant

2669. Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/studies/index.html?page=147
      January 01, 2024 - Keywords: Adverse Drug Events (ADE), Adverse Events, Patient Safety, Medication: Safety, Medication

2670. Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/studies/index.html?page=122
      January 01, 2024 - Keywords: Antibiotics, Medication: Safety, Medication, Adverse Drug Events (ADE), Adverse Events

2671. Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/studies/index.html?page=174
      January 01, 2024 - claims for patients aged 65 and older who underwent percutaneous coronary interventions (PCIs) with drug-eluting

2672. Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/studies/index.html?page=216
      January 01, 2024 - Keywords: Heart Disease and Health, Cardiovascular Conditions, Blood Thinners, Medication, Adverse Drug

2673. Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/studies/index.html?page=219
      January 01, 2024 - Pharmacoepidemiol Drug Saf 2019 May;28(5):640-48. doi: 10.1002/pds.4750..

2674. COIN: Collaborative Ohio Inquiry Network (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/resources/COIN.pdf
      May 01, 2015 - Through OCTC, COIN is building the capacity to conduct Phase 3 & 4 clinical drug and device trials in

2675. Final Progress Report: Utility of Predictive Systems in Diagnostic Errors (UPSIDE) (pdf file)
      www.ahrq.gov/sites/default/files/2025-02/auerbach-report.pdf
      January 01, 2025 - outcomes such as infections due to urinary catheters, ventilator-associated pneumonia, or adverse drug

2676. CHIPRA 194: Section 1, Tables 1-5 (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-194-section-1-tables-1-5.pdf
      April 01, 2019 - related to psych factors 307.81 Cluster headaches/other trigeminal autonomic cephaligias 339.0x Drug

2677. Final Progress Report: Advancing Patient Identity Management in the Context of Real-World Health Information Exchange (pdf file)
      www.ahrq.gov/sites/default/files/2024-07/grannis-report.pdf
      January 01, 2024 - not only to determine a patient's healthcare status,but also for clinical effectiveness research, drug

2678. 2018 National Healthcare Quality and Disparities Report: Appendix A (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2018qdr-appa6.pdf
      January 01, 2018 - adults age 40 and over 5.36 0.81 HCUP 2016 People age 12 and over who needed treatment for illicit drug … population per year 6.04 7.78 NVSS_M 2016 People age 12 and over who needed treatment for illicit drug … congestive heart failure 12.13 3.05 HCUP 2016 People age 12 and over who needed treatment for illicit drug … aneurysm (AAA) repair -3.10 -0.30 HCUP 2016 People age 12 and over who needed treatment for illicit drug … last 12 months -27.58 -2.36 NSDUH 2016 People age 12 and over who needed treatment for illicit drug

2679. 2014-Women-Chartbook (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/chartbooks/2014-women-chartbook.pdf
      January 01, 2014 - Adverse drug events occur in 15% or more of older patients presenting to offices, hospitals, and extended … Adverse effects of medical care can arise from medical and surgical procedures as well as from adverse drug … Reducing the risk of adverse drug events in older adults.

2680. Medication Reconciliation in Pediatric Mental Health Care Settings: Detailed Measure Specifications (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/medication-reconciliation/chipra-0179-technicalspecs.pdf
      January 21, 2020 - Medication Reconciliation in Pediatric Mental Health Care Settings: Detailed Measure Specifications Medication Reconciliation in Pediatric Mental Health Care Settings Detailed Measure Specifications A. Description This measure set outlines a set of constructs that provide a framework of desirable attri…